Trump's antibody treatment under trial at 2 Michigan hospitals
DETROIT — Clinical trials are underway at two hospitals in Michigan for the cocktail of monoclonal antibodies that President Donald Trump has credited for his quick recovery from COVID-19.Grand Rapid’s Butterworth Hospital and Beaumont-Royal Oak Hospital are studying the treatment developed by Tarrytown, New York-based Regeneron Pharmaceuticals. The drug REGN-COV2 contains two potent, complementary virus-neutralizing antibodies. The synthetic antibodies were created in the laboratory to specifically target the SARS-CoV-2 virus that causes COVID-19.“It’s an interesting approach, and we think it...
The Detroit News
Nation and world news briefs
US-run clinical trial of Eli Lilly antibody therapy to endEli Lilly & Co. said a clinical trial of its experimental antibody therapy in hospitalized COVID-19 patients will end, after the U.S. government-run study was paused earlier this month.The company said in a statement that the decision was based on data suggesting the treatment is unlikely to help hospitalized COVID-19 patients recover from the advanced stage of their disease.On Oct. 14, the Indianapolis drug giant said enrollment had been paused in the so-called ACTIV-3 trial of its neutralizing monoclonal antibody treatment sponsored b...
Tribune News Service
Monoclonal antibodies could fill the COVID-19 treatment gap until vaccines arrive — but at a cost
SEATTLE — With a positive test, a monster headache and fever of 101 degrees, Joanne Gieselman said “sure” when offered the chance to participate in a trial of an experimental treatment for COVID-19, the illness caused by the coronavirus. The 63-year old Redmond woman wasn’t sick enough to need hospitalization — yet — but her age and some pulmonary scarring from childhood raised her anxiety and risk levels.“I do know people who died of this,” she said. “I was afraid this wicked virus could cause a very adverse reaction if it went into my lungs.”So Gieselman spent an hour in a bed at EvergreenHe...
The Seattle Times
UC Davis conducting clinical trials of experimental drug that Trump took for coronavirus
SACRAMENTO, Calif. — Dr. Timothy Albertson said Friday evening that he hopes COVID-19 patients at Sacramento’s University of California, Davis Medical Center will be willing to join a clinical trial of the experimental antibody cocktail that President Donald Trump said he’s taking to combat the disease.“There are trials where they focus on outpatients, and Dr. Stu Cohen (also with UCD) is involved in one of those trials where patients who have been exposed to family members or workers who have known disease can enroll in that trial,” Albertson said. “My trial with this drug is with patients wh...
The Sacramento Bee
Convalescent plasma is latest COVID-19 therapy
DETROIT — Richard Beckerson will never know whether it was convalescent plasma that made the lifesaving difference — or whether it was the antiviral drug remdesivir or a combination of both.To him, it doesn’t really matter. All that matters is that he survived 122 days of hospitalization with COVID-19, and he’s back now in his Dearborn Heights home with his wife, Rebecca.“I had a lot of prayers going on,” said Beckerson, 74, a retired car salesman. “So you know, I’m sure God looked down and said, ‘Who in the heck is this Rich Beckerson that everyone is praying for?’ Anyways, it worked.”He was ...
Detroit Free Press